BioMarin Pharmaceutical Inc (BMRN) Total liabilities 2016–2025
BioMarin Pharmaceutical Inc (BMRN) total liabilities at each fiscal year-end, per SEC filings.
$1.5BFY2025 · since FY2016: $1.3B → $1.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.5B | +13.2% |
| FY2024 | $1.3B | -29.6% |
| FY2023 | $1.9B | +6.7% |
| FY2022 | $1.8B | +1.9% |
| FY2021 | $1.7B | -0.2% |
| FY2020 | $1.7B | +11.1% |
| FY2019 | $1.6B | +7.4% |
| FY2018 | $1.5B | -20.0% |
| FY2017 | $1.8B | +45.1% |
| FY2016 | $1.3B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice